GPCM

Granite Point Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,000	Closed	-$611K	–	133
2022 Q1	$611K	Sell	20,000 -5,000	-20%	-$153K	0.13%	76
2021 Q4	$781K	Buy	+25,000	New	+$781K	0.13%	77
2021 Q3	–	Sell	-110,000	Closed	-$2.05M	–	166
2021 Q2	$2.05M	Buy	110,000 +40,000	+57%	+$745K	0.08%	59
2021 Q1	$1.25M	Sell	70,000 -69,360	-50%	-$1.24M	0.05%	87
2020 Q4	$2.14M	Sell	139,360 -2,300	-2%	-$35.4K	0.11%	55
2020 Q3	$1.57M	Hold	141,660	–	–	0.09%	50
2020 Q2	$1.78M	Hold	141,660	–	–	0.09%	50
2020 Q1	$1.61M	Sell	141,660 -130,883	-48%	-$1.48M	0.91%	30
2019 Q4	$3.57M	Sell	272,543 -23,957	-8%	-$314K	0.56%	11
2019 Q3	$2.67M	Sell	296,500 -6,800	-2%	-$61.3K	0.42%	14
2019 Q2	$2.99M	Hold	303,300	–	–	0.2%	15
2019 Q1	$3.08M	Buy	303,300 +50,000	+20%	+$508K	0.3%	17
2018 Q4	$1.6M	Sell	253,300 -211,000	-45%	-$1.33M	0.32%	23
2018 Q3	$6.13M	Sell	464,300 -17,900	-4%	-$236K	0.41%	3
2018 Q2	$4.44M	Buy	+482,200	New	+$4.44M	0.4%	12